The first invasive Candida auris infection in Taiwan

Emerg Microbes Infect. 2022 Dec;11(1):1867-1875. doi: 10.1080/22221751.2022.2100280.

Abstract

Candida auris, a multidrug resistant pathogenic yeast, has spread worldwide and caused several outbreaks in healthcare settings. Here, we report the first case of C. auris candidemia in Taiwan in a patient with a two-month history of hospitalization in Vietnam. We performed further investigation on the isolate from the present case as well as the previously reported C. auris isolate identified from a wound in 2018 in Taiwan, which was the first case reported in Taiwan. Both C. auris isolates were found to be susceptible to fluconazole, amphotericin B, and echinocandins. Additionally, mutations in ERG11 or FKS1 were not detected in either isolate. Microsatellite genotyping revealed that both isolates belonged to the South Asian clade. In recent years, C. auris has emerged as a global concern, and differences in clades and susceptibility patterns mandate further awareness and systematic surveillance.

Keywords: Candida auris; South Asian clade; Taiwan; antifungal susceptibility; candidemia; epidemiology.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Candida / genetics
  • Candida auris*
  • Candidiasis
  • Candidiasis, Invasive* / drug therapy
  • Candidiasis, Invasive* / epidemiology
  • Humans
  • Microbial Sensitivity Tests
  • Taiwan / epidemiology

Substances

  • Antifungal Agents

Supplementary concepts

  • Candida auris infection
  • Systemic candidiasis